Adjunctive Betamethasone Treatment of Hypoxemic Adults Hospitalized with Mycoplasma Pneumoniae Community-Acquired Pneumonia: An Open-Label, Multicenter, Randomized, Controlled Trial
This study suggests that adding corticosteroids to standard antibiotic therapy may improve clinical outcomes, particularly in severe CAP, by reducing inflammation and disease progression. The benefit appears most pronounced in patients with significant hypoxemia, where inflammatory response contributes to respiratory compromise. Importantly, the study supports a growing body of evidence favoring targeted steroid use in selected CAP populations rather than routine use in all patients. Clinical implications: This reinforces considering adjunctive corticosteroids in severe CAP—especially hypoxemic patients—while balancing risks such as immunosuppression and tailoring decisions to disease severity and etiology. Full Access: The Lancet
WHO Prequalifies First-Ever Malaria Treatment for Newborns and Infants, Adds New Diagnostic Tests
The World Health Organization announced the prequalification of the first malaria treatment specifically designed for newborns and young infants that meets global standards for safety, quality, and efficacy. This innovation addresses a critical treatment gap, as infants were previously treated with formulations for older children, increasing risks of dosing errors and toxicity. The initiative also includes the addition of new rapid diagnostic tests to improve detection amid evolving parasite characteristics. Clinical implications: These advances aim to expand access to appropriate treatment and strengthen malaria control efforts in high-burden regions. Full Acces: WHO
Increase in Poison Center Reports Linked to Kratom-Containing Kava Products — National Poison Data System, United States, 2000–2025
The Centers for Disease Control and Prevention MMWR report describes a rising trend in poison center exposures linked to kratom-containing kava products in the United States from 2000–2025. The data show increasing case volume over time, with a subset resulting in moderate to severe clinical outcomes, including hospitalization. Co-ingestion with substances such as alcohol, benzodiazepines, or kratom was common and associated with more serious toxicity. These findings highlight the growing public health concern around unregulated herbal and supplement products with psychoactive effects. Clinical implications: clinicians should actively screen for supplement use in patients with unexplained neurologic or systemic symptoms and counsel patients on potential risks, particularly when combined with other substances. Full Access: CDC
CDC Data Show Weekly ER Visits for Tick Bites Higher than Usual
This report highlights that emergency department visits for tick bites in 2026 are higher than expected nationwide, reaching the highest levels for this time of year since 2017 in most regions. Tick bites have more than doubled typical seasonal rates in some weeks, reflecting an early and intense tick season with increased exposure risk. Clinical implications: This surge underscores the need for heightened vigilance, early recognition of tick-borne disease symptoms, and consideration of empiric treatment in appropriate cases to prevent complications. Full Access: CDC